In the News
Iya Khalil weighs in on AI in Real-World Drug Discovery
Following the recent Bio-IT conference, Iya Khalil and fellow keynote panelists weigh in on how AI is impacting real-world drug discovery efforts. Read the full article here.
read more
GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report evaluates the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. They gather data on each nominee’s professional background...
read more
Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News
"AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets." - Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to discuss AI in drug...
read moreEvents
Colin Hill Discusses AI and Machine Learning in Cancer Medicine at Milken Institute
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at the Milken Institute Global Conference to discuss the impact of AI and machine learning on cancer medicine, including: Mike Nohaile, Senior Vice President of Strategy, Commercialization...
read more
Colin Hill speaks on AI and Machine Learning in Cancer Medicine at Milken Institute 2019 Global Conference
The panel will focus on uses of ‘artificial intelligence and machine learning’ for cancer early detection, diagnosis, drug development and clinical decision making. These technologies have the potential to accelerate our understanding of cancer at the cellular and the...
read more
Iya Khalil joins Plenary Keynote Panel on AI in Bio-IT at Bio-IT World Conference
Iya Khalil, GNS Healthcare's Chief Operating Officer and Co-founder, will be featured on the panel "AI in Practice: How New Technologies are Changing Bio-IT" at the Bio-IT World Conference on Wednesday April 17th at 8:00am. The conference is highlighting the...
read morePress Releases
Scott Gottlieb to Keynote GNS Healthcare’s Precision Medicine Forum
23rd FDA Commissioner to share his thoughts on the convergence of data and AI in the development and use of new medicines along with industry luminaries from biopharma, payers, and patient foundations CAMBRIDGE, Mass., June 3, 2019 /PRNewswire/ -- GNS Healthcare...
read moreBusiness Health Care Group of Wisconsin Partners with GNS Healthcare to Improve Value of Care Across State
Innovative use of causal artificial intelligence to reveal the practices of medicine that drive improved health outcomes at lower costs MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 -- The Business Health Care Group (BHCG), a coalition of employers located...
read moreGNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read more